Data suggest that semaglutide may lower the 10-year risk of developing type 2 diabetes by as much as 60% in people with overweight and weight-related complications or with obesity while on treatment
Lyte M, Daniels KM, Schmitz-Esser S (2019) Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects
Complications secondary to the use of SGLT2 inhibitors in oncological patients: A series of 5 cases
However, weight loss averages 46% at 14 mg, significantly lower than seen with newer trials
Trinity-X is a 39-amino-acid synthetic peptide engineered as a tri-agonist for the GLP-1, GIP, and glucagon receptors
If you have low testosterone, HRT is likely your best treatment option